RX & Associates Pharmacy Expert Witness, Standards of Care ,DUI, Medical Malpractice & Clinical Pharmacology
- PO BOX 7502 STOCKTON , CA 95267
Currently serve as an Editorial Consultant for the well respected Pharmacist Letter and Prescriber’s Letter, Pharmacy Technician’s Letter,
Advocates Prescription Drug Safety
I have also worked for a national pharmacy chain since 1992. Employed as a Pharmacy Manager for that company.
I currently serve on the editorial staff of several national Drug Therapy newsletters:
-Pharmacy Technician’s Letter
-Pain Physician –The official Journal of the American Society of Interventional Pain Physicians
-Canadian Pharmacist's Letter
-Journal of Drug Intoxication & Detoxification: Novel Approaches
2012; 15;S67-S116. American Society of Interventional Pain Physicians (ASIPP) Guidelines for Responsible Opioid Prescribing in Chronic Non-Cancer Pain:(Link)
Sleep Physiology, Abnormal States, and Therapeutic Interventions Alvah T. Wickboldt, Alex F. Bowen, Aaron J. Kaye, Adam M. Kaye, Franklin Rivera Bueno and Alan D. Kaye(Link)
Benzodiazepine Pharmacology and Central Nervous System–Mediated Effects(Link)
The Ochsner Journal
Charles E.GriffinIII, Adam M. Kaye, Franklin Rivera Bueno, and Alan D. Kaye (2013) Benzodiazepine Pharmacology and Central Nervous System–Mediated Effects. The Ochsner Journal: Summer 2013, Vol. 13, No. 2, pp. 214-223.
Benzodiazepine Pharmacology and Central Nervous System–Mediated Effects
Charles E. Griffin III , MD*, Adam M. Kaye , Pharm D†,.
) Intraoperative Pulseless Electrical Activity and Acute Cardiogenic Shock After Administration of Phenylephrine, Epinephrine, and Ketamine. Alan D. Kaye, Alecia L. Sabartinelli, Adam M. Kaye, Alan M. Holtzman, and Paul L. Samm (2010The Ochsner Journal: Fall 2010, Vol. 10, No. 3, pp. 205-209.
Ident-a-drug Reference: For Drug Tablet and Capsule Identification(Link)
Therapeutic Research Center,J. Jellin, Timothy Swaim, Linda Van, Adam Marc Kaye, Shelby Butler, Linda Hneitina-----Co-author 1999-2011----(2012,2013- currently available online)
Pharmacists Letter, Feb 1, 2004 - Reference - 703 pages . Identifies drug products by the codes imprinted on them. Includes brand name and generic products, from the United States and Canada. Gives a description of each product's colors, shape,..
Essentials of Pharmacology for Anesthesia, Pain Medicine, and Critical Care with Black Box Warnings Kaye, Alan David; Kaye, Adam M.; Urman, Richard D. (Eds.) 2014, XXX, 828 p. 224 illus., 32 illus. in color.(Link)
Springer-The editors and contributors are pharmacology experts representing a cross-section of clinical specialties and institutions in the United States and include pharmacologists, pharmacists,physicians
FDA “black box” warnings
Basic principles and practical clinical information, e.g., indications, side effects, dosing, and drug interactions
Concepts and medications frequently tested on standardized exams
Designed for daily consultation
Suitable for practitioners, trainees, and students
Designed for Anesthesiology, pain medicine, and critical care, practitioner
QT interval abnormalities: risk factors and perioperative management in long QT syndromes and Torsades de
Journal of Anesthesia/Springer
published in the following paginated issue of Journal of Anesthesia: Volume 27, Issue 4 (2013), Page 575-587
Perioperative analgesia and the effects of dietary supplements
Best Practice & Research Clinical Anaesthesiology Volume 28, Issue 2, Pages 183–189, June 2014
With over 50,000 dietary supplements available, resurgence in consumer interest over the past few decades has resulted in an explosion of use of these agents worldwide. Disillusionment with current medications and belief in “natural medicines” has resulted in a multibillion dollar industry. Active ingredients in a number of herbs are being tested for therapeutic potential, and some are efficacious.
Opioid Antagonists: Will they Solve all of the Problems Associated with Opioid Agonists?
Global Journal of Anesthesiology is a peer reviewed, academic and elevated scope journal
Physicians employed in operating and emergency rooms have utilized opioid antagonist for almost half a century for the treatment of opioid overdose. The prototype antagonist remains naloxone hydrochloride, which actually received FDA approval back in 1971. Why after so many years on the market is this medication now being formulated in the form of an easy to use “auto-injector” that was designed.
Basic Concepts in Opioid Prescribing and Current Concepts of Opioid-Mediated Effects on Driving(Link)
The Ochsner Journal > Winter 2013
Background: Many patients with chronic pain receive substandard analgesic therapy. Incomplete or inadequate care often stems from physician fears of patient addiction and/or drug toxicity. As a result, many chronic pain patients are undertreated and have unrelieved pain that tempts them to overuse or to abuse prescribed pharmacologic treatments. In the last few years, educational efforts have.
California Pharmacist with prescribing authority. "Mid-Level Practitioner,"
Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist with prescribing authority "Mid-Level Practitioner"
Clinical Professor of Pharmacy/Pharmacy Manager/ Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist
Dr. Adam Marc Kaye, Pharm.D., R.PH., FASCP, FCPhA, is California Licensed Pharmacist and Clinical Professor of Pharmacy, Department of Pharmacy Practice at the University of the Pacific’s Thomas J. Long School of Pharmacy. Dr. Kaye has also been employed by a national pharmacy company since 1992 as Staff Pharmacist and is currently a Pharmacy Manager.
Pharmacist-Clinical Professor of Pharmacy
University of the Pacific
Provide instruction to pharmacy students/interns on the identification of drug related adverse effects and the appropriate use of and pharmacology of medications to be better able to apply relative information to patients and be able to respond to drug information questions. Provide first and second year pharmacy students/interns to Experiential Clinical Practice to increase knowledge of disease states, contraindications and adverse effects, and to identify, resolve, and prevent drug-related problems, reduction, prevention and identification of adverse drug reactions and medication errors.
EDITORIAL ADVISORY BOARD MEMBER
Therapeutic Research Center
I have also been involved for many years with Therapeutic Research Center as a co-author of its Ident-A-Drug medication reference. This valuable reference book and website provides pharmacies, emergency rooms, law enforcement agencies, and poison control centers a quick and accurate way of identifying tablets and capsules that are not in a labeled vial or bottle.
Adam M. Kaye received his doctor of pharmacy degree in 1995 from University of the Pacific. Dr. Kaye is heavily involved in the San Joaquin Pharmacists Association, having served four previous terms as president, and the California Pharmacists Association. He is also Editorial Advisor for Pharmacist Letter, Prescriber’s Letter, and the Pharmacy Technician Letter. In addition, he has been the coauthor of the well-known Ident-A-Drug reference book since the late 1990s and has coauthored numerous chapters in pain and anesthesia textbooks. Dr. Kaye also continues to work at the University of the Pacific preparing students for pharmacy practice.
Adam M. Kaye ‘95 was a coauthor for the following book chapters: “Special Concerns Regarding Commonly Prescribed Drugs,” in Understanding Pain: What You Need to Know to Take Control, Praeger (September 2011); and “Pharmacology,” in Moderate and Deep Sedation in Clinical Practice, Cambridge University Press (December 2011).
Adam M. Kaye ‘95 coauthored the book chapter “Anticoagulation and Regional Anesthesia Considerations” for Essentials of Regional Anesthesia, published by Springer (December 2011).
Adam Kaye ‘95 had his co-authored chapter “Anticoagulation and Regional Anesthesia Concerns,” published in Essentials of Regional Anesthesia, Kaye, Urman and Vadivelu, eds. (Springer, 2012).
“Understanding Pain-What You Need to Know to Take Control”, Editors: Alan D. Kaye, MD, PhD, and Richard D.Urman, MD, MBA, Editors. Chapter 7, “Special Concerns Regarding Commonly Prescribed Drugs” Adam M. Kaye ‘95 and Alan D. Kaye. ISBN: 0313396035,9780313396038. In Press.
“Moderate and Deep Sedation in Clinical Practice”, Editors: Richard D. Urman and Alan D. Kaye.Chapter-2- Pharmacology. Julie Gayle, MD, Alan D. Kaye, MD,PhD, Adam M. Kaye ‘95, Pharm.D. ISBN: 1107400457,978110740045. In press.
“Foundations-Comprehensive Pain Medicine and Interventional Pain Management Review” Chapter 6- Ryan P. Ellender, MD, Alan D. Kaye, MD, PhD, Adam M. Kaye, Pharm.D.”Neuroleptic Drugs”, and Chapter 10 M.Tyler Stout, MD, Alan D. Kaye, MD, Phd, Adam M. Kaye, Pharm.D. -“Muscle Relaxants and Antispacticity Drugs”, Chapter 11-Brad J. Hynel MD, Alan D. Kaye, MD, Phd, Adam M. Kaye ‘95, Pharm.D. “NMDA Receptor Antagonists” in press.
“Foundations-Comprehensive Pain Medicine and Interventional Pain Management Review” Chapters 6- Ryan P. Ellender, MD, Alan D. Kaye, MD, PhD, Adam M. Kaye ‘95, Pharm.D.”Neuroleptic Drugs
“Foundations-Comprehensive Pain Medicine and Interventional Pain Management Review” Chapter 10 M.Tyler Stout, MD, Alan D. Kaye, MD, Phd, Adam M. Kaye ‘95, Pharm.D. -“Muscle Relaxants and spacity Drugs”
“Foundations-Comprehensive Pain Medicine and Interventional Pain Management Review” Chapter 11-Brad J. Hynel MD, Alan D. Kaye, MD, Phd, Adam M. Kaye ‘95, Pharm.D. “NMDA Receptor Antagonists” 2011.
“Essentials of Regional Anesthesia”, edited by Drs. Alan David Kaye, Richard D. Urman, and Nalini Vadivelu.Chapter 6: “Anticoagulation and Regional Anesthesia Considerations” Rhinoo V. Shah, Alan D. Kaye, Adam M. Kaye ‘95, and Jeffrey Y. Tsai, in press.
“Ident-A-Drug Reference” Publisher: Pharmacists Letter 2011 Co-Author Adam M. Kaye ‘95 Pharm.D.,FASCP,FCPHA
Adam M. Kaye ‘95 was a contributor to AMERICAN SOCIETY OF INTERVENTIONAL PAIN PHYSICIANS (ASIPP) Pain Medicine & Interventional Pain Management “Board Review Self-Assessment”. 2011. American Society of Interventional Pain Physicians.
Mirapex (pramipexole), Requip (ropinirole) and Impulse Control Disorders . June 18, 2012 . Featured Articles-RxEconsult, LLC. Author: Adam Kaye ‘95, PharmD –
Anticoagulants and Medications that Increase Risk of Bleeding. June 16, 2012. Featured Articles- RxEconsult, LLC. Authors: Adam M. Kaye ‘95 Pharm.D. & Jessica S. Kaye-
Over-the-Counter (OTC) Antihistamines for Allergies. Featured Articles-RxEconsult, LLC. June 16, 2012. Author: by Adam Kaye ‘95, PharmD –
Over-the-Counter (OTC) Products for Insomnia. Featured Articles- RxEconsult, LLC. June 15, 2012. Authors: Adam M. Kaye ‘95 Pharm.D. and Jessica S. Kaye
Opioid+NSAID Combinations and Stomach Bleeding. Featured Articles- RxEconsult, LLC. June 15, 2012 Authors: Adam M. Kaye ‘95 Pharm.D. & Jessica S. Kaye
Should Statins be Used by Individuals with Low Risk for Heart Disease. Featured Articles- RxEconsult, LLC. June 15, 2012 . Authors: Adam M. Kaye ‘95 Pharm.D. & Jessica S. Kaye
Prescription and Over-The-Counter (OTC) Acne Preparations. Featured Articles- RxEconsult, LLC. June 14, 2012. Authors: Adam M. Kaye ‘95 Pharm.D. & Jessica S. Kaye
Should Vicodin and other Hydrocodone Products be Switched to Schedule II. . Featured Articles- RxEconsult, LLC. Author: Adam Kaye ‘95, PharmD – June 2, 2012
How PBMs Affect the Future of Community Pharmacy. Featured Articles-RxEconsult, LLC. Author: Adam Kaye ‘95, PharmD – June 3, 2012
How to Become a Pharmacist Expert Witness. Featured Articles- RxEconsult, LLC. Author: Adam Kaye ‘95, PharmD – May 31, 2012
Alvah T. Wickboldt, Alex F. Bowen, Aaron J. Kaye, Adam M. Kaye ‘95, Franklin Rivera Bueno, Alan D. Kaye, (2012) Sleep Physiology, Abnormal States, and Therapeutic Interventions. The Ochsner Journal: Summer 2012, Vol. 12, No. 2, pp. 122-134.